Acoustic effects of lamotrigine in pediatric patients with epilepsy

Brain and Development

Volumn 33, Issue 5, 2011, Pages 374-378

  Yun, Minseon ^a   Choi, Yoon Mi ^a   Eun, So Hee ^b   Seol, In Joon ^c   Kim, Sun Jun ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Korea University   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

Acoustic variation; Epilepsy; Lamotrigine

Indexed keywords

LAMOTRIGINE;

ADOLESCENT; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CHILD; COMPLEX PARTIAL SEIZURE; CONSONANT; DRUG DOSE INCREASE; ELECTROENCEPHALOGRAPHY; FEMALE; GENERALIZED EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCLONUS EPILEPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PITCH; PRESCHOOL CHILD; SCHOOL CHILD; SPEECH ARTICULATION; SPEECH RATE; VOICE ONSET TIME;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; SPEECH; SPEECH ACOUSTICS; TRIAZINES; VOICE;

EID: 79954601043     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2010.07.007     Document Type: Article

References (34)

1. Clarke T., Strug L.J., Murphy P.L., Bali B., Carvalho J., Foster S., et al. High risk of reading disability and speech sound disorder in rolandic epilepsy families: case-control study. Epilepsia 2007, 48:2258-2265.
2. Roll P., Rudolf G., Pereira S., Royer B., Scheffer I.E., Massacrier A. SRPX2 mutations in disorders of language cortex and cognition. Hum Mol Genet 2006, 15:1195-1207.
3. Borgatti R., Piccinelli P., Passoni D., Dalpra L., Miozzo M., Micheli R., et al. Relationship between clinical and genetic features in "inverted duplicated chromosome 15" patients. Pediatr Neurol 2001, 24:111-116.
4. Scheffer I.E. Autosomal dominant rolandic epilepsy with speech dyspraxia. Epileptic Disord 2000, 2(Suppl. 1):S19-S22.
5. Caplan R., Siddarth P., Bailey C.E., Lanphier E.K., Gurbani S., Shields W.D., et al. Thought disorder: A developmental disability in pediatric epilepsy. Epilepsy Behav 2006, 8:726-735.
6. Nicolai J., Aldenkamp A.P., Arends J., Weber J.W., Vles J.S. Cognitive and behavioral effects of nocturnal epileptiform discharges in children with benign childhood epilepsy with centrotemporal spikes. Epilepsy Behav 2006, 8:56-70.
7. Riva D., Vago C., Franceschetti S., Pantaleoni C., D'Arrigo S., Granata T., et al. Intellectual and language findings and their relationship to EEG characteristics in benign childhood epilepsy with centrotemporal spikes. Epilepsy Behav 2007, 10:278-285.
8. Northcott E., Connolly A.M., Berroya A., Sabaz M., McIntyre J., Christie J., et al. The neuropsychological and language profile of children with benign rolandic epilepsy. Epilepsia 2005, 46:924-930.
9. Northcott E., Connolly A.M., Berroya A., McIntyre J., Christie J., Taylor A., et al. Memory and phonological awareness in children with benign rolandic epilepsy compared to a matched control group. Epilepsy Res 2007, 75:57-62.
10. Monjauze C., Tuller L., Hommet C., Barthez M.A., Khomsi A. Language in benign childhood epilepsy with centro-temporal spikes abbreviated form: rolandic epilepsy and language. Brain Lang 2005, 92:300-308.
11. Yung A.W., Park Y.D., Cohen M.J., Garrison T.N. Cognitive and behavioral problems in children with centrotemporal spikes. Pediatr Neurol 2000, 23:391-395.
12. Chard D.J., Dickson S.V. Phonological awareness: Instructional and assessment guidelines. Intervent School Clinic 1999, 34:261-270.
13. Shankweiler D., Crain S., Katz L., Fowler A.E., Liberman A.M., Brady S.A., et al. Cognitive profiles of reading-disabled children: comparison of language skills in phonology, morphology, and syntax. Psychol Sci 1995, 6:149-156.
14. Cohen H., Le Normand M.T. Language development in children with simple-partial-left-hemisphere-epilepsy. Brain Lang 1998, 64:409-422.
15. Deonna T.W., Roulet E., Fontan D., Marcoz J.P. Speech oromotor deficits of epileptic origin in benign partial epilepsy of childhood with rolandic spikes (BPERS): Relationship to the acquired Aphasia-Epilepsy syndrome. Neuropediatrics 1993, 24:83-87.
16. Papavasiliou A., Mattheou D., Bazigou H., Kotsalis C., Paraskevoulakos E. Written language skills in children with benign childhood epilepsy with centrotemporal spikes. Epilepsy Behav 2005, 6:50-58.
17. Caplan R., Siddarth P., Stahl L., Lanphier E., Vona P., Gurbani S., et al. Childhood absence epilepsy: Behavioral, cognitive, and linguistic comorbidities. Epilepsia. 2008, 49:1838-1846.
18. Park J.I., Kim S.J., Kim H.G. Acoustic effects of carbamazepine in benign rolandic epilepsy. Epilepsy Behav 2005, 7:468-471.
19. Aldenkamp A.P., De Krom M., Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia 2003, 44:21-29.
20. Brunbech L., Sabers A. Effect of antiepileptic drugs on cognitive function in individuals with epilepsy. Drugs 2002, 62:593-604.
21. Kossoff E.H., Los J.G., Boatman D.F. A pilot study transitioning children onto levetiracetam monotherapy to improve language dysfunction associated with benign rolandic epilepsy. Epilepsy Behav 2007, 11:514-517.
22. Weintraub D., Buchsbaum R., Resor S.R., Hirsch L.J. Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy. Epilepsy Behav 2007, 10:105-110.
23. Lacy CF, Armstrong LL, Goldman MP, Lance LL. Drug information handbook: a comprehensive resource for all clinicians and healthcare professionals, 15th ed. Lexi-Comp; p. 898-917.
24. Bootsma H.P., Vos A.M., Hulsman J., Lambrechts D., Leenen L., Majoie M., et al. Lamotrigine in clinical practice. Long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy Behav 2008, 12:262-268.
25. LaRoche S.M., Helmers S.L. The new antiepileptic drugs. JAMA 2004, 291:605-614.
26. Wheless J.W., Clarke D.F., Arzimanoqlou A., Carpenter D. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord 2007, 9:353-412.
27. Neels H.M., Sierens A.C., Naelaerts K., Scharpe S.L., Hatfield G.M., Lambert W.E. Therapeutic drug monitoring of old and newer antiepileptic drugs. Clin Chem Lab Med 2004, 42:1228-1255.
28. Matsuo F. Lamotrigine. Epilepsia 1999, 40:S30-S36.
29. Brodie M.J., Richens A., Yuen A.W.C. Double-blinded comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995, 345:476-479.
30. Steiner T.J., Dellaportas C.I., Findley L.J. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia 1999, 40:601-607.
31. Kaminow L., Schimschock J.R., Hammer A.E., Vuong A. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy. Epilepsy Behav 2003, 4:659-666.
32. Khan A., Ginsberg L.D., Asnis G.M., Goodwin F.K., Davis K.H., Krishnan A.A., et al. Effect of lamotrigine on cognitive complaints in patients with bipolar disorder. J Clin Psychiatry 2004, 65:1483-1490.
33. Meador K.J., Baker G.A. Behavioral and cognitive effects of lamotrigine. J Child Neurol 1997, 12:S44-S47.
34. Nadkarni S., Devinsky O. Current review in clinical science-psychotropic effects of antiepileptic drugs. Epilepsy Currents 2005, 5:176-181.